
Oxolife
Operator of a biotechnology company intended to improve female fertility. The company's drug acts directly on the endometrium to enhance embryo implantation and restore ovulation, enabling clinicians ...
Valuation
$0
Share Price
N/A
Total Raised
$17.1M
Last Round
N/A